Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

S Paul, E Candelario-Jalil - Experimental neurology, 2021 - Elsevier
Stroke is the leading cause of disability and thesecond leading cause of death worldwide.
With the global population aged 65 and over growing faster than all other age groups, the …

Protein tyrosine phosphatases as potential therapeutic targets

R He, Z Yu, R Zhang, Z Zhang - Acta pharmacologica sinica, 2014 - nature.com
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

MH Kramer, Q Zhang, R Sprung, RB Day… - Blood, The Journal …, 2022 - ashpublications.org
We have developed a deep-scale proteome and phosphoproteome database from 44
representative acute myeloid leukemia (AML) patients from the LAML TCGA dataset and 6 …

Regulation of affect by the lateral septum: implications for neuropsychiatry

TP Sheehan, RA Chambers, DS Russell - Brain Research Reviews, 2004 - Elsevier
Substantial evidence indicates that the lateral septum (LS) plays a critical role in regulating
processes related to mood and motivation. This review presents findings from the basic …

The NMDA receptor as a target for cognitive enhancement

GL Collingridge, A Volianskis, N Bannister, G France… - …, 2013 - Elsevier
NMDA receptors (NMDARs) play an important role in neural plasticity including long-term
potentiation and long-term depression, which are likely to explain their importance for …

Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP

J Xu, P Kurup, Y Zhang, SM Goebel-Goody… - Journal of …, 2009 - Soc Neuroscience
NMDA receptor (NMDAR)-mediated excitotoxicity plays an important role in several CNS
disorders, including epilepsy, stroke, and ischemia. Here we demonstrate the involvement of …

Fyn kinase inhibition as a novel therapy for Alzheimer's disease

HB Nygaard, CH van Dyck, SM Strittmatter - Alzheimer's research & …, 2014 - Springer
Alzheimer's disease (AD) is a devastating neurodegenerative disorder, afflicting more than
one-third of people over the age of 85. While many therapies for AD are in late-stage clinical …

Role of NMDA Receptor‐Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies

FJ Carvajal, HA Mattison, W Cerpa - Neural plasticity, 2016 - Wiley Online Library
N‐Methyl‐D‐aspartate receptors (NMDARs) have two opposing roles in the brain. On the
one hand, NMDARs control critical events in the formation and development of synaptic …

Targeting Fyn kinase in Alzheimer's disease

HB Nygaard - Biological psychiatry, 2018 - Elsevier
The past decade has brought tremendous progress in unraveling the pathophysiology of
Alzheimer's disease (AD). While increasingly sophisticated immunotherapy targeting soluble …

ApoE, ApoE receptors, and the synapse in Alzheimer's disease

C Lane-Donovan, J Herz - Trends in Endocrinology & Metabolism, 2017 - cell.com
As the population ages, neurodegenerative diseases such as Alzheimer's disease (AD) are
becoming a significant burden on patients, their families, and health-care systems …